Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :i

    

• Evidence-Based Review

  • ·Treatments for pulmonary sarcoidosis

    Page :1-9

    Shanthi Paramothayan, Toby Lasserson

    Résumé Résumé Plan Plan  

• Review

  • ·Importance of inhaler devices in the management of airway disease

    Page :10-19

    J.C. Virchow, G.K. Crompton, R. Dal Negro, S. Pedersen, A. Magnan, J. Seidenberg, P.J. Barnes

    Résumé Résumé Plan Plan  

• Original Articles

  • ·Intervention by phone calls raises domiciliary activity and exercise capacity in patients with severe COPD

    Page :20-26

    Alexandra R. Wewel, Iska Gellermann, Ingrid Schwertfeger, Matthias Morfeld, Helgo Magnussen, Rudolf A. Jörres

    Résumé Résumé Plan Plan  
  • ·Presence and treatment of air hunger in severely ill patients

    Page :27-31

    Nathan M. Shumway, Ramey L. Wilson, Robin S. Howard, Joseph M. Parker, Arn H. Eliasson

    Résumé Résumé Plan Plan  
  • ·A randomized study of tiotropium Respimat^® Soft Mist^TM Inhaler vs. ipratropium pMDI in COPD

    Page :32-41

    T. Voshaar, R. Lapidus, R. Maleki-Yazdi, W. Timmer, E. Rubin, L. Lowe, E. Bateman

    Résumé Résumé Plan Plan  
  • ·Methacholine-induced asthma symptoms correlate with impulse oscillometry but not spirometry

    Page :42-49

    Adel H. Mansur, Sarah Manney, Jon G. Ayres

    Résumé Résumé Plan Plan  
  • ·Improvements with tiotropium in COPD patients with concomitant asthma

    Page :50-56

    H. Magnussen, B. Bugnas, J. van Noord, P. Schmidt, F. Gerken, S. Kesten

    Résumé Résumé Plan Plan  
  • ·Dispensing of antibiotics, antitussives and mucolytics to asthma patients: A pharmacy-based observational survey

    Page :57-63

    Laurent Laforest, Eric Van Ganse, Gilles Devouassoux, A. El Hasnaoui, Liesl M. Osman, Gisele Bauguil, Genevieve Chamba

    Résumé Résumé Plan Plan
  • ·Lung-uptake and -washout of MIBG in sarcoidosis

    Page :64-70

    Gerard J. Jonker, Nanda M. Smulders, Marinus J. van Kroonenburgh, Serve Halders, Jolanda de Vries, Carin G. Faber, Marjolein Drent

    Résumé Résumé Plan Plan  
  • ·Effectiveness of omalizumab (Xolair^®) in the first patients treated in real-life practice in France

    Page :71-76

    Mathieu Molimard, Frédéric de Blay, Alain Didier, Vincent Le Gros

    Résumé Résumé Plan Plan  
  • ·Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma

    Page :77-81

    Pierre Ernst, Edmee Franssen, Charles K.N. Chan, Marni Okell, Paul O’Byrne, Tony Bai

    Résumé Résumé Plan Plan
  • ·Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples

    Page :82-91

    Marzia Simoni, Laura Carrozzi, Sandra Baldacci, Marco Borbotti, Francesco Pistelli, Francesco Di Pede, Sara Maio, Anna Angino, Giovanni Viegi

    Résumé Résumé Plan Plan  
  • ·Costs of chronic obstructive pulmonary disease (COPD) in Italy: The SIRIO study (Social Impact of Respiratory Integrated Outcomes)

    Page :92-101

    R.W. Dal Negro, S. Tognella, R. Tosatto, M. Dionisi, P. Turco, C.F. Donner

    Résumé Résumé Plan Plan  
  • ·Weight loss and asthma control in severely obese asthmatic females

    Page :102-108

    Mauro Maniscalco, Anna Zedda, Stanislao Faraone, Maria Rosaria Cerbone, Stefano Cristiano, Cristiano Giardiello, Matteo Sofia

    Résumé Résumé Plan Plan  
  • ·Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease—A population-based study

    Page :109-120

    Marie Ekberg-Aronsson, Kerstin Löfdahl, Jan-Åke Nilsson, Claes-Göran Löfdahl, Peter M. Nilsson

    Résumé Résumé Plan Plan  
  • ·DOTS implementation in a post-war, United Nations-administered territory: Lessons from Kosovo

    Page :121-127

    Bahri Tigani, Xhevat Kurhasani, Lisa V. Adams, Gazmend Zhuri, Rukije Mehmeti, Daniela Cirillo, Max Salfinger, Alka Dev, Lucica Ditiu, Giovanni Battista Migliori

    Résumé Résumé Plan Plan  
  • ·Anti-endothelial cell antibodies in patients with interstitial lung diseases

    Page :128-133

    Takashi Matsui, Naoki Inui, Takafumi Suda, Kingo Chida

    Résumé Résumé Plan Plan  
  • ·NT-proBNP is not elevated in patients with obstructive sleep apnoea

    Page :134-142

    Ralf-Harto Hübner, Nour Eddine El Mokhtari, Sandra Freitag, Tim Rausche, Robert Göder, Andreas Tiroke, Markus Lins, Rüdiger Simon, Burkhard Bewig

    Résumé Résumé Plan Plan  
  • ·Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma

    Page :143-149

    Tracey A. Bradshaw, Simon P. Matusiewicz, Graham K. Crompton, J. Alastair Innes, Andrew P. Greening

    Résumé Résumé Plan Plan  
  • ·Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease

    Page :150-155

    Ana C. Zamora, Paul J. Wolters, Harold R. Collard, M. Kari Connolly, Brett M. Elicker, W. Richard Webb, Talmadge E. King, Jeffrey A. Golden

    Résumé Résumé Plan Plan  
  • ·Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma

    Page :156-161

    Rosângela Silveira D’Ávila, Jefferson P. Piva, Paulo José Cauduro Marostica, Sérgio Luís Amantea

    Résumé Résumé Plan Plan
  • ·The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation

    Page :162-171

    Rosalie J. Huijsmans, Arnold de Haan, Nick N.H.T. ten Hacken, Renata V.M. Straver, Alex J. van’t Hul

    Résumé Résumé Plan Plan  

• Letter to The Editor

  • ·CHKS data should be avoided when investigating mortality

    Page :172

    Craig J. Currie